drugset / Trial / NCT01210430

Local Vasoconstriction in Postural Tachycardia Syndrome

NCT01210430

Phase 0 Completed 74 enrolled New York Medical College
RandomizedCrossoverDouble-blindDiagnostic

Summary

The investigators study will determine how often blood flow regulation abnormalities and abnormalities of sympathetic regulation produced by nitric oxide, angiotensin-II, and oxidative stress occur in POTS and the mechanism(s) of POTS in individual patients. Specific causes for POTS may vary from patient to patient. Patients will be compared to healthy control subjects. There is a treatment arm with a medication (losartan) that reduces the binding of angiotensin and increases NO. If the investigators know the specific biochemical mechanism the investigators may be able to offer further specific treatments to specific patients.

Timeline

Start
2010-07
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Losartan Other / unclassified 50 mg
Comparator Vitamin C Other / unclassified 20 mg/kg